OLIVIA COCHRAN: Open Payments
NPI 1184176786 · BUCHANAN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 8 payments from 4 companies in 2025. Trend: 2023 $786 · 2024 $274 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $84 |
| Novo Nordisk Inc | 3 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $33 |
Products named: COBENFY, Rybelsus, Ozempic, TRELEGY ELLIPTA, LEQVIO, ENTRESTO, SHINGRIX.
Industry payments across MI — which companies pay providers there.
